Production of epidermal growth factor related ligands in tumorigenic and benign human lung epithelial cells

Cancer Letters

Volumn 142, Issue 1, 1999, Pages 55-63

  Fernandes, Audrey M ^a,b   Hamburger, Anne W ^b   Gerwin, Brenda I ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Epidermal growth factor; Human lung epithelial cells; Transforming growth factor

Indexed keywords

EPIDERMAL GROWTH FACTOR; TRANSFORMING GROWTH FACTOR ALPHA;

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG ALVEOLUS EPITHELIUM; LUNG CANCER; NUDE MOUSE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; EPIDERMAL GROWTH FACTOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, ERBB-2; HUMANS; LIGANDS; LUNG; LUNG NEOPLASMS; MICE; NEOPLASMS, EXPERIMENTAL; RECEPTOR, ERBB-2; TRANSFORMING GROWTH FACTOR ALPHA;

MUS MUSCULUS;

EID: 0033050422     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00166-4     Document Type: Article

References (25)

1. Johnson B.E. Biological and molecular prognostic factors - impact on treatment of patients with non-small cell lung cancer. Chest. 107:1995;287S-289S.
2. Salomon D.S., Brandt R., Ciardiello F., Normanno N. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit. Rev. Oncol. Hematol. 19:1995;183-232.
3. Alroy I., Yarden Y. The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions. FEBS Lett. 410:1997;83-86.
4. Beerli R.R., Hynes N.E. Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities. J. Biol. Chem. 271:1996;6071-6076.
5. Riese D.J., Bermingham Y., van Raaji T., Buckley S., Plowman G., Stern D.F. Betacellulin activates the epidermal growth factor receptor and ErbB4 and induces cellular response patterns distinct from those stimulated by epidermal growth factor or heregulin. Oncogene. 12:1996;345-353.
6. Gamett D.C., Pearson G., Cerione R.A., Friedberg I. Secondary dimerization between members of the epidermal growth factor receptor family. J. Biol. Chem. 272:1997;12052-12056.
7. Olayioye M.A., Graus-Porta D., Beerli R., Rohrer J., Gay B., Hynes N.E. ErbB-1 and ErbB-2 acquire distinct signaling properties dependent upon their dimerization partner. Mol. Cell. Biol. 18:1998;5041-5042.
8. Imanishi K., Yamaguchi K., Kuramami M. Inhibition of human lung adenocarcinoma cell lines by anti-transforming growth factor-alpha monoclonal antibody. J. Natl. Cancer Inst. 81:1989;220-223.
9. Rachwal W.J., Bongiorno P.F., Orringer M.B., Whyte R.I., Ethier S.P., Beer D.G. Expression and activation of ErbB-2 and epidermal growth factor receptors in lung adenocarcinomas. Br. J. Cancer. 72:1994;56-64.
10. Tateishi M., Ishida T., Mitsudomi T. Immunohistochemical evidence of autocrine growth factor in adenocarcinoma of the human lung. Cancer Res. 50:1990;7072-7080.
11. Fontanini G., De Laurentiis M., Vignati V., Chine S., Lucchi M., Silvestri V., Mussi A., De Placido S., Tortora G., Bianco A., Gullick W., Angeletti C., Bevilacqua G., Ciardiello F. Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected Stage I-IIIA non-small cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survival. Clin. Cancer Res. 4:1998;1-9.
12. Rusch V., Baselga J., Cordon-Cardo C., Orazem J., Zaman M., Hoda S., McIntosh J., Kurie J., Dmitrosviy E. Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung. Cancer Res. 53:1993;2379-2385.
13. Hamburger A.W., Fernandes A., Murakami M., Gerwin B.I. The role of transforming growth factor alpha production and ErbB2 overexpression in induction of tumorigenicity of lung epithelial cells. Br. J. Cancer. 77:1998;1066-1071.
14. Reddel R.R., Ke Y., Gerwin B.I., McMenamin M.G., Lechner J.F., Su R.T., Brash D.E., Park J.B., Rhim J.S., Harris C.C.H. Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus12-SV40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes. Cancer Res. 48:1988;1904-1909.
15. Noguchi M., Murakami M., Bennett W., Lupu R., Hui F. Jr, Harris C.C., Gerwin B.I. Biological consequences of overexpression of a transfected cerbB2 gene in immortalized human bronchial epithelial cells. Cancer Res. 53:1993;2035-2043.
16. Lupu R., Colomer R., Kannan B., Lippman M. Characterization of a growth factor that binds exclusively to the ErbB-2 receptor and induces cellular responses. Proc. Natl. Acad. Sci. USA. 89:1992;2287-2291.
17. Holmes W.E., Sliwkowski M.X., Akita R.W., Henzel W.J., Lee J., Park J.W., Yansura D., Abadi N., Raab H., Lewis G.D., Shepard H.M., Juang W.J., Wood W.I., Goeddel D.V., Vandlen R.L. Identification of heregulin, a specific activator of p185erbB2. Identification of heregulin, a specific activator of p185erbB2. Science. 256:1992;1205-1210.
18. Wen D., Suggs S.V., Karunagaran D., Liu N., Cupples R.L., Luo Y., Janssen A.M., BenBaruch N., Trollinger D.B., Jacobsen V.L., Meng S., Lu H., Hu S., Chang D., Yang W., Yanigahara D., Koski R., Yarden Y. Structural and functional aspects of the multiplicity of Neu differentiation factors. Mol. Cell Biol. 14:1994;1909-1919.
19. Mincione G., Bianco C., Kannan S., Colletta G., Ciardiello F., Sliwkowski M., Yarden Y., Normanno N., Pramaggiore A., Kim N., Salomon D.S. Enhanced expression of heregulin in cerbB2 and cHaras transformed mouse and human mammary epithelial cells. J. Cell. Biochem. 60:1996;437-446.
20. Johnson G.R., Kannan B., Shoyab M., Stromberg K. Amphiregulin induces tyrosine phosphorylation of the epidermal growth factor receptor and p185erbB2 - evidence that amphiregulin acts exclusively through the epidermal growth factor receptor at the surface of human epithelial cells. J. Biol. Chem. 268:1993;2924-2931.
21. Wang L.M., Kuo A., Alimandi M., Veri M.C., Lee C.C., Kapoor V., Ellmore N., Chen X.H., Pierce J.H. ErbB2 expression increases the spectrum and potency of ligand-mediated signal transduction through ErbB4. Proc. Natl. Acad. Sci. USA. 95:1998;6809-6814.
22. Tsao M.S., Zhu H., Viallet J. Autocrine growth loop of the epidermal growth factor receptor in normal and immortalized human bronchial epithelial cells. Exp. Cell Res. 223:1996;268-273.
23. Alimandi M., Wang L.M., Bottaro D., Lee C.C., Kuo A., Frankel M., Fedi P., Tang C., Lippman M., Pierce J.H. Epidermal growth factor and betacellulin mediate signal transduction through coexpressed ErbB2 and ErbB3 receptors. EMBO J. 16:1997;5608-5617.
24. Pinkas-Kramarski R., Lenferink A.E., Bacus S.S., Lyass L., van de Poll M.L., Klapper N.L., Tzahar E., Sela M., van Zoelen E.J., Yarden Y. The oncogenic ErbB2/ErbB3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin. Oncogene. 16:1998;1249-1258.
25. Normanno N., Selvam M., Qi C.F., Saeki F., Johnson G., Kim N., Ciardiello F., Shoyab M., Plowman G., Brandt R., Todaro G., Salomon D.S. Amphiregulin as an autocrine growth factor for c-Ha-ras and c-erbB-2 transformed human mammary epithelial cells. Proc. Natl. Acad. Sci. USA. 91:1996;2790-2794.